Delivery of interleukin-12 in gelatin hydrogels effectively suppresses development of transplanted colonal carcinoma in mice

Cancer Chemotherapy and Pharmacology

Volumn 51, Issue 1, 2003, Pages 53-57

  Liu, Lili ^a   Sakaguchi, Takeo ^a   Kanda, Tatsuo ^a   Hitomi, Jiro ^a   Tabata, Yasuhiko ^b   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Antineoplastic cytokine; Biodegradable cytokine; Mouse; Pharmacokinetics

Indexed keywords

GELATIN; INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CANCER INHIBITION; CLINICAL OBSERVATION; COLON CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISTRIBUTION; FEEDING BEHAVIOR; LIVER LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; COLONIC NEOPLASMS; GELATIN; HYDROGELS; INTERLEUKIN-12; MALE; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION;

EID: 0037222123     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-002-0547-y     Document Type: Article

References (21)

1. Brunda MJ, Gately MK (1995) Interleukin-12: Potential role in cancer therapy. In: De Vita VT, Hellman S, Rosenberg S (eds) Important Advances in Oncology, J.B. Lippincott, Philadelphia, p 3
2. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF, Gately MK (1993) Antitumor and anti-metastatic activity of interleukin 12 against murine tumors. J Exp Med 178:1223
3. Brunda MJ, Luistro L, Rumennik L, Wright RB, Dvorozniak M, Aglione A, Wigginton JM, Wiltrout RH, Hendrzak JA, Palleroni AV (1996) Antitumor activity of interleukin 12 in preclinical models. Cancer Chemother Pharmacol [Suppl] 38:S16
4. Colombo MP, Vagliani M, Spreafico F, Parenza M, Chiodoni C, Melani C, Stoppacciaro A (1996) Amount of interleukin 12 available at the tumor site is critical for tumor regression. Cancer Res 56:2531
5. Cui X, Sakaguchi T, Shirai Y, Hatakeyama K (1999) Orally administered panax ginseng extract decreases platelet adhesiveness in 66% hepatectomized rats. Am J Chin Med 27:251
6. Franks LM, Hemmings VJ (1978) A cell line from an induced carcinoma of mouse rectum. J Pathol 124:35
7. Fujiwara H, Hamaoka T (1996) Antitumor and antimetastatic effects of interleukin 12. Cancer Chemother Pharmacol [Suppl] 38:S22
8. Funahashi Y, Koyanagi N, Sonoda J, Kitoh K, Yoshimatsu K (1999) Rapid development of hepatic metastasis with high incidence following orthotopic transplantation of murine colon 38 carcinoma as intact tissue in syngeneic C57BL/6 mice. J Surg Oncol 71:83
9. Gately MK, Warrier RR, Honasoge S, Carvajal DM, Faherty DA, Connaughton SE, Anderson TD, Sarmiento U, Hubbard BR, Murphy M (1994) Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo. Int Immunol 6:157
10. Giuliani FC, Zirvi KA, Kaplan NO (1981) Therapeutic response of human tumor xenografts in athymic mice to doxorubicin. Cancer Res 41:325
11. Hong L, Tabata Y, Miyamoto S, Yamamoto M, Yamada K, Hashimoto N, Ikada Y (2000) Bone regeneration at rabbit skull defects treated with transforming growth factor-β1 incorporated into hydrogels with different levels of biodegradability. J Neurosurg 92:315
12. Kang HW, Tabata Y, Ikada Y (1999) Fabrication of porous gelatin scaffolds for tissue engineering. Biomaterials 20:1339
13. Kikuchi T, Joki T, Abe T, Ohno T (1999) Antitumor activity of killer cells stimulated with both interleukin-2 and interleukin-12 on mouse glioma cells. J Immunother 22:245
14. Kuriakose MA, Chen FA, Egilmez NK, Jong YS, Mathiowitz E, DeLacure MD, Hicks WL Jr, Loree TL, Bankert RB (2000) Interleukin-12 delivered by biodegradable microspheres promotes the antitumor activity of human peripheral blood lymphocytes in a human head and neck tumor xenograft/SCID mouse model. Head Neck 22:57
15. Shah AU, D'Souza MJ (1999) Sustained-release interleukin-12 microspheres in the treatment of cancer. Drug Dev Ind Pharm 25:995
16. Stern AS, Magram J, Presky DH (1996) Interleukin-12 an integral cytokine in the immune response. Life Sci 58:639
17. Tabata Y, Ikada Y (1999) Vascularization e3ect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials 20:2169
18. Taetle R, Rosen F, Abramson I, Venditti J, Howell S (1987) Use of nude mouse xenografts as preclinical drug screens: In vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts. Cancer Treat Rep 71:297
19. Tahara H, Zeh HJ 3rd, Storkus WJ, Pappo I, Watkins SC, Gubler U, Wolf SF, Robbins PD, Lotze MT (1994) Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res 54:182
20. Trinchieri G (1995) Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen- specific adaptive immunity. Annu Rev Immunol 13:251
21. Zitvogel L, Tahara H, Robbins PD, Storkus WJ, Clarke MR, Nalesnik MA, Lotze MT (1995) Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. J Immunol 155:1393